| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
75 |
| Employees |
13,900 |
| Revenues (TTM) (Millions $) |
3,875 |
| Net Income (TTM) (Millions $) |
817 |
| Cash Flow (TTM) (Millions $) |
-91 |
| Capital Exp. (TTM) (Millions $) |
127 |
Business Description
Bard C R Inc, also known as CR Bard, is a global medical technology company that specializes in the development, manufacturing, and commercialization of medical devices and surgical products. The company was founded in 1907 and is headquartered in Murray Hill, New Jersey, in the United States.
CR Bard operates in three major business segments, namely Peripheral Vascular, Urology and Oncology, and Surgical Specialties. The company's products are used in a wide range of medical procedures and applications, including hernia repair, women's health, cardiovascular disease, oncology, and others.
The Peripheral Vascular division of CR Bard produces a range of products to treat conditions such as deep vein thrombosis, pulmonary embolism, and peripheral artery disease. These products include catheters, filters, stents, and other devices.
The Urology and Oncology division of Bard CR Inc deals with devices and products that provide solutions for various urological conditions. The company produces products such as catheters, urine drainage systems, and biopsy needles, among others.
The Surgical Specialties segment of the company provides surgical products that are primarily used in procedures such as hernia repair, soft tissue repair, and breast reconstruction. Some of the products in this segment include meshes, surgical markers, and implantable fixation devices.
The company has a global presence and operates in over 100 countries. CR Bard employs over 15,000 people and has manufacturing facilities in the United States, Europe, and Asia. In 2017, Bard reported sales of $3.3 billion.
In summary, Bard C R Inc is a major player in the global medical technology industry, specializing in the manufacturing and distribution of medical devices and surgical products. The company operates in several business segments and has a global presence. It has a long history of innovation and has been at the forefront of medical device technology for over a century.
|
%
75.94 %